Broad Institute of MIT and Harvard Press Releases

• Published on April 6, 2022 - 15:00 GMT

  

  Two large studies reveal genes and genome regions that influence schizophrenia risk

  In a landmark genetic study of more than 121,000 people, an international consortium called SCHEMA, led by researchers at the Broad Institute of MIT and Harvard, has identified extremely rare protein-disrupting mutations in 10 genes that strongly increase …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on March 21, 2019 - 10:00 GMT

  

  Academic institutions grant license for CRISPR-based SHERLOCK in developed world, protect rights for use in developing world

  A group of academic institutions has granted a license for SHERLOCK™, the highly-sensitive, low-cost CRISPR-based diagnostic, for commercial uses in the developed world, while reserving rights to enable its broad use by organizations to serve developing …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on March 18, 2019 - 04:05 GMT

  

  Sumaiya Iqbal is using computer science to bridge genetics and therapeutics

  When a 15-year-old Sumaiya Iqbal was asked about her career aspirations in a televised profile series about the most promising young students in Bangladesh, she confidently responded that she wanted to become “a scientist.” At the time, she was thinking of …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on March 15, 2019 - 17:21 GMT

  

  Research Roundup: March 15, 2019

  Welcome to the March 15, 2019 installment of Research Roundup, a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators. A data flood from young bloods For a systems biology look at how the human body …

  Distribution channels: Healthcare & Pharmaceuticals Industry
• Published on March 8, 2019 - 16:48 GMT

  

  Research Roundup: March 8, 2019

  Welcome to the March 8, 2019 installment of Research Roundup, a recurring snapshot of recent studies published by scientists at the Broad Institute and their collaborators. Exhausted, but still effective It’s unclear how anti-PD1 “checkpoint-blockade” …

  Distribution channels: Healthcare & Pharmaceuticals Industry